Are presynaptic GABA-Cρ2 receptors involved in anti-nociception?
R Tadavarty1, J Hwang1, P S Rajput2
1Neuroscience Research Laboratory, Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Neuroscience Letters
|September 2, 2015
Summary
This study shows that GABA-C receptors in the central nervous system play a role in pain regulation. Blocking these receptors reduced the pain-relieving effects of a GABA-C agonist, highlighting their potential in pain management.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- GABA receptors are crucial in central nervous system function.
- The role of GABA-C receptors in pain modulation is not fully understood.
Purpose of the Study:
- To investigate the anti-nociceptive effects of GABA-C receptors.
- To determine the involvement of GABA-C receptors in pain regulation within the central nervous system.
Main Methods:
- Intracisternal injections of GABA-C and GABA-A receptor agonists (CACA and isoguvacine).
- Administration of a GABA-C receptor antagonist (TPMPA).
- Assessment of anti-nociceptive effects via tail-withdrawal latency.
- Double-labelled immunofluorescence studies of GABA-Cρ2 receptor expression.
Main Results:
- Both GABA-C and GABA-A receptor agonists increased tail-withdrawal latency.
- The GABA-C antagonist TPMPA blocked the effects of the GABA-C agonist but not the GABA-A agonist.
- GABA-Cρ2 receptors were found to be expressed presynaptically in the spinal dorsal horn, particularly in the substantia gelatinosa.
Conclusions:
- GABA-C receptors are involved in the central nervous system's regulation of pain.
- Presynaptic GABA-C receptors in the spinal dorsal horn may play a significant role in controlling nociception.
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.8K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
01:30Transducer Mechanism: G Protein–Coupled Receptors
8.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.2K
01:12GPCR Desensitization
8.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.8K
01:31Adrenergic Receptors: ɑ Subtype
3.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.3K
01:22Opioid Receptors: Overview
6.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.7K